Zylox-Tonbridge Medical Technology Co., Ltd. has filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, reporting the repurchase of 626,000 shares at an aggregate price of HKD 959,880. These shares will be held as treasury shares. The disclosure follows the company's repurchase mandate approved on 30 May 2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zylox-Tonbridge Medical Technology Co .Ltd. published the original content used to generate this news brief on June 18, 2025, and is solely responsible for the information contained therein.